| Literature DB >> 25470614 |
Roland Devlieger1, Isabelle Guelinckx2, Goele Jans3, Willy Voets4, Caroline Vanholsbeke5, Greet Vansant2.
Abstract
BACKGROUND: Studies report frequent micronutrient deficiencies after bariatric surgery, but less is known about micronutrient levels of pregnant women after bariatric surgery.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25470614 PMCID: PMC4254913 DOI: 10.1371/journal.pone.0114192
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Overview of the prescribed supplements for each micronutrient deficiency.
| Folate | Folavit | 1 x/day = 4 mg/day |
| Iron | Fero-Grad 500 | 1 x/day = 105 mg Fe2+ |
| Vitamin B-12 | Neurobion | 1x/month = 500-1000 µg IM |
| Vitamin A | Omnibionta prenatal | 1x/day = Vit C 180 mg, nicotinamide 20 mg, vit E 12 mg, vit B-5 10 mg, Provit A 3 mg, vit B-6 2.2 mg; vit B-2 1.6 mg, vit B-9 200 µg, vit B-8 100 µg, vit D 10 µg, vit B-12 2.7 µg, Mg 70 mg, Fe 28 mg, Zn 15 mg, Mn 1 mg, DHA 200 mg, vit E 12 mg |
| Vitamin D + Calcium | D-Vital forte | 1 x/day = calciumcarbonate 2.5 g+, colecalciferol 880 IU, 1 g Ca2+ |
| Vitamin B-1 | Befacte Forte | 1-3x/day |
| Multivitamin | Omnibionta prenatal | 1x/day = Vit C 180 mg, nicotinamide 20 mg, vit E 12 mg, vit B-5 10 mg, Provit A 3 mg, vit B-6 2.2 mg; vit B-2 1.6 mg, vit B-9 200 µg, vit B-8 100 µg, vit D 10 µg, vit B-12 2.7 µg, Mg 70 mg, Fe 28 mg, Zn 15 mg, Mn 1 mg, DHA 200 mg, vit E 12 mg |
Abbreviations: vitamin (vit), milligram (mg), gram (g), intramuscular (IM), microgram (µg), international unit (IU), Magnesium (Mg), Iron (Fe), Zinc (Zn), Manganese (Mn), Docosahexaenoic Acid (DHA)
Baseline characteristics of the study population according to type of bariatric surgery.
| Baseline characteristic | Restrictive procedure(N = 18) | Malabsorptive procedure(N = 31) | P-value |
| Gestational age at inclusion (weeks) | 9.5±2.2 (6–12) | 10.7±2.5 (6-13) | 0.075 |
| Age (years) | 30.4±3.2 (25-36) | 29.6±5.5 (18-38) | 0.506 |
| Height (m) | 1.7±0.1 (1.50–1.74) | 1.7±0.1 (1.54–1.79) | 0.838 |
| Preoperative weight (kg) | 108.6±13.5 (88–140) | 116.0±19.9 (86–150) | 0.205 |
| Preoperative Body Mass Index (kg/m2) | 40.0±4.9 (31–50) | 42.4±6.4 (29–57) | 0.178 |
| Maximum postoperative weight loss (kg) | 30.3±12.6 (16–57) | 49.7±15.5 (22–80) | 0.001 |
| Interval between surgery and conception (months) | 44.9±28.9 (4–108) | 34.5±26.9 (2–96) | 0.198 |
| Prepregnancy weight (kg) | 85.7±15.1 (63–110) | 72.7±13.7 (54–112) | 0.008 |
| Prepregnancy Body Mass Index (kg/m2) | 31.6±5.8 (22–44) | 26.6±4.3 (22–39) | 0.002 |
| Nulliparae | 6 (33) | 13 (42) | 0.551 |
| Smokers | 6 (33) | 6 (19) | 0.316 |
Values presented as mean ± SD (range) or n (valid percentage).
Figure 1Mean (±SD) concentrations of various markers of nutritional/health status.
light grey = malabsorptive group. dark grey = restrictive group. 1 = significant time effect. 2 = significant group effect. 3 = significant time x group effect.
Proportion of deficiencies (%) across pregnancy and according to group.
| Total population (N = 49) | Restrictive procedure(N = 18) | Malabsorptive procedure(N = 31) | p-value group | |
| Albumin <35 g/l | ||||
| 1st trimester | 7 | 15 | 3 | 0.165 |
| 2nd trimester | 21 | 33 | 15 | 0.221 |
| 3rd trimester | 74 | 91 | 65 | 0.115 |
| P-value trimester | 0.001 | 0.011 | 0.001 | |
| Hemoglobin <11 g/dl | ||||
| 1st trimester | 28 | 29 | 28 | 0.946 |
| 2nd trimester | 63 | 44 | 73 | 0.048 |
| 3rd trimester | 76 | 71 | 79 | 0.397 |
| P-value trimester | 0.001 | 0.247 | 0.001 | |
| MCV <76 fL | ||||
| 1st trimester | 12 | 29 | 3 | 0.016 |
| 2nd trimester | 9 | 13 | 7 | 0.459 |
| 3rd trimester | 26 | 41 | 14 | 0.060 |
| P-value trimester | 0.156 | 0.717 | 0.174 | |
| Vitamin B-12 <191 ng/l | ||||
| 1st trimester | 35 | 31 | 37 | 0.709 |
| 2nd trimester | 45 | 39 | 48 | 0.564 |
| 3rd trimester | 41 | 58 | 32 | 0.281 |
| P-value trimester | 0.735 | 0.156 | 0.311 | |
| Ferritin <30 µg/l | ||||
| 1st trimester | 27 | 14 | 33 | 0.186 |
| 2nd trimester | 54 | 36 | 63 | 0.097 |
| 3rd trimester | 42 | 55 | 36 | 0.319 |
| P-value trimester | 0.076 | 0.174 | 0.093 | |
| Folic Acid <252 µg/l | ||||
| 1st trimester | 3 | 0 | 4 | 0.698 |
| 2nd trimester | 0 | 0 | 0 | 0.693 |
| 3rd trimester | 0 | 0 | 0 | 0.379 |
| P-value trimester | 0.202 | 0.368 | 0.236 | |
| Vitamin B-1 <70 nmol/l | ||||
| 1st trimester | 2 | 0 | 4 | 0.558 |
| 2nd trimester | 5 | 0 | 7 | 0.235 |
| 3rd trimester | 17 | 6 | 26 | 0.257 |
| P-value trimester | 0.002 | 0.135 | 0.011 | |
| Vitamin A <300 µg/l | ||||
| 1st trimester | 19 | 18 | 19 | 0.885 |
| 2nd trimester | 40 | 56 | 31 | 0.098 |
| 3rd trimester | 58 | 56 | 59 | 0.861 |
| P-value trimester | 0.005 | 0.205 | 0.013 | |
| 25-OH-Vitamin D <7 µg/l | ||||
| 1st trimester | 14 | 12 | 16 | 0.538 |
| 2nd trimester | 7 | 13 | 4 | 0.499 |
| 3rd trimester | 6 | 12 | 0 | 0.199 |
| P-value trimester | 0.030 | 0.368 | 0.135 | |
| 25-OH-Vitamin D 7–20 µg/l | ||||
| 1st trimester | 26 | 35 | 20 | 0.538 |
| 2nd trimester | 21 | 19 | 23 | 0.499 |
| 3rd trimester | 36 | 29 | 42 | 0.199 |
| P-value trimester | 0.368 | 0.565 | 0.197 | |
| Vitamin E <5.0 mg/l | ||||
| 1st trimester | 2 | 0 | 3 | 0.447 |
| 2nd trimester | 0 | 0 | 0 | 0.662 |
| 3rd trimester | 0 | 0 | 0 | 0.235 |
| P-value trimester | 0.368 | 0.607 | 0.368 |
Values presented as proportion (%).
Association between supplement intake and micronutrient deficiency across the different pregnancy trimesters.
| Reported vitamin/mineral supplement | ||||
| Micronutrient deficiency | No | Multivitamin/mineral | Additional supplement | P-value |
| Trimester 1 | Trimester 1 | 0.380 | ||
| Yes (n = 40) | 3 (7.5) | 23 (57.5) | 14 (35.0) | |
| No (n = 9) | 2 (22.2) | 5 (35.6) | 2 (22.2) | |
| Trimester 2 | Trimester 1 | 0.273 | ||
| Yes (n = 45) | 4 (8.9) | 25 (55.6) | 16 (35.6) | |
| No (n = 4) | 1 (25.0) | 3 (75.0) | 0 | |
| Trimester 2 | 0.377 | |||
| Yes (n = 43) | 2 (4.4) | 8 (17.8) | 33 (73.3) | |
| No (n = 4) | 1 (25.0) | 1 (25.0) | 2 (50.0) | |
| Trimester 3 | Trimester 1 | 0.668 | ||
| Yes (n = 43) | 5 (11.6) | 24 (55.8) | 14 (32.6) | |
| No (n = 6) | 0 | 4 (66.7) | 2 (33.3) | |
| Trimester 2 | 0.839 | |||
| Yes (n = 41) | 3 (7.0) | 8 (18.6) | 30 (69.8) | |
| No (n = 6) | 0 | 1 (16.7) | 5 (83.8) | |
| Trimester 3 | 0.545 | |||
| Yes (n = 41) | 8 (18.6) | 3 (7.0) | 30 (73.2) | |
| No (n = 6) | 0 | 1 (16.7) | 5 (83.3) | |
Values presented as n (valid percentage).
Maternal and neonatal outcomes.
| Restrictive procedure (N = 18) | Malabsorptive procedure (N = 31) | P-value | |
| Pregnancy duration (weeks) | 39.28±1.40 (36–42) | 38.31±2.15 (29–41) | 0.094 |
| Gestational weight gain (kg) | 13.06±8.05 (0–30) | 12.77±6.06 (2–23) | 0.892 |
| Birth weight (kg) | 3.43±0.47 (2.62–4.16) | 3.06±0.56 (0.95–4.13) | 0.024 |
| Infant length (cm) | 49.94±1.67 (47–53) | 49.15±1.66 (46–53) | 0.092 |
| Gestational diabetes | 1 (7.7%) | 1 (5.6%) | 1.000 |
| Pregnancy induced hypertension | 2 (11%) | 3 (10%) | 1.000 |
| Chronic hypertension | 0 | 0 | - |
| Preeclampsia | 0 | 1 (3%) | 1.000 |
| Induction of labor | 3(17%) | 3 (10%) | 0.798 |
| Caesarean section | 3 (17%) | 9 (30%) | 0.624 |
| Preterm birth <37 weeks | 1 (6%) | 4(13%) | 0.639 |
| Low birth weight (<2.5 kg) | 0 (0%) | 2 (7%) | 0.526 |
| Macrosomia (> 4.0 kg) | 3 (17%) | 1 (3%) | 0.134 |
| Shoulder dystocia | 0 | 0 | - |
| Low Apgar score at 1 min (<4) | 0 | 1 (3%) | 0.311 |
| Low Apgar score at 5 min (<4) | 0 | 0 | - |
| Admission at neonatal intensive care | 1 (6%) | 3 (10%) | 0.587 |
Values presented as n (valid percentage).